KLF9 and hepatocellular carcinoma: Furthermore, recent evidence indicates that FABP5 facilitates HCC progression through the CREB/miR-889-5p/KLF9 signaling pathway, underscoring its potential as a promising therapeutic and prognostic target in HCC (56).